Substituted pyrazolo[1,5-a]pyrimidines as apelin receptor agonists
US11345705B2 · kind B2 · utility
1Cited by
0References
26Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 8, 2018 |
| Grant date | May 31, 2022 |
| Priority date | — |
| Expiry date | Aug 8, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P31/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are agonists of the apelin receptor of Formula (I): for the treatment of disease. The compounds disclosed herein are useful for the treatment of a range of cardiovascular, renal and metabolic conditions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.